Remove Data Management Remove Laws Remove Manufacturing
article thumbnail

Is my Software a Medical Device? Use the Digital Health Policy Navigator

FDA Law Blog

If you are a manufacturer of implants that go into the human body for the treatment of disease, it’s an easy yes that you are a manufacturer of a medical device. Manufacturers of software products should determine whether their software functions are excluded from the definition of a device. Clinical Decision Support Software.

article thumbnail

As the Calendar Turns, Cybersecurity Remains Key Focus of Digital Health Enforcement

FDA Law Blog

It emphasizes building partnerships with local health and law enforcement authorities, so organizations can mitigate any breaches, especially those that can potentially cripple smaller, less resourced providers. Digital providers and manufacturers not only have the concerns of the FDA to consider, but those of the FTC as well.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

White House Unveils Drug Control Plan Emphasizing Treatment and Harm Reduction

The Crime Report

It calls for changes in state laws and policies to support the expansion of the practice. borders; improving data systems and research that guide drug policy; and making sure the people most in danger of overdose can get evidence-based treatments, including people experiencing homelessness and those in prison or jail.

article thumbnail

The 4 Ingredient Categories Your People Analytics Framework Needs to be Effective

The Process Street

This isn’t always the simplest task, however – particularly in today’s knowledge economy where the value of human capital is a much more complex issue than in an industrial or manufacturing-based economy. Data management. Change management. Stakeholder management. Data & infrastructure.

article thumbnail

Fraud-on-the-FDA As A Basis for A False Claims Act Lawsuit: Is It Dead Or Just Resting?

FDA Law Blog

established by statute and case law. The DOJ notes that “device manufacturers are required to investigate adverse events and report information to the FDA within 30 days of becoming aware of information that the marketed device “[h]as malfunctioned. . . This fraudulent inducement theory is well?established